Skin Cancer

Skin and Oral Cavity Cancer (CMN)

Following the approval from the Institutional Review Board (IRB), IFO is initiating their first study of Alpha DaRT for the treatment of Skin Cancer of all types including Squamous Cell Carcinoma (SCC), Basal Cell Carcinoma (BCC), Merkel Cell Carcinoma (MCC) and Melanoma. Those types of skin cancer are called Cutaneous and Mucosal malignant Neoplasia (CMN).

 

The trials in Rome will be led by principal investigator Laura Eibenschutz, MD, Medical Director at the Department of Oncological Dermatology from IFO, ISG. “With strong, well-published findings from preclinical trials in over 6000 animals in different types of tumors, we are proud to start Alpha TAU’s first trial investigating the Alpha DaRT as a treatment for Cutaneous and Mucosal malignant Neoplasia (CMN),” said Dr. Laura Eibenschutz, IFO. 

 

The treatment for CMN, similar to SCC, is conducted under local anesthesia in a regular procedure room. No special shielding or equipment is required.

 

Each patient is treated under local anesthesia in a single short session. The treatment is delivered by inserting Alpha DaRT seeds into to the tumor. Using ultra-minimally invasive applicators minimizes patient discomfort and improves the aesthetic outcome of the procedure. The Alpha DaRT seeds are stringed on a suture which enables the seeds’ removal according to the doctor's decision and evaluation of necessity.

 

In most cases, the patient is released from the clinic immediately after the procedure. Follow-up examinations are conducted throughout the trial to ensure the patient’s safety and to record necessary data.

Institutes

Treatment of Cutaneous and Mucosal malignant Neoplasia (CMN) is currently running at:

 

Istituti Fisioterapici Ospitalieri (I.F.O.)

The Istituti Fisioterapici Ospitalieri (I.F.O.), Physiotherapeutic Hospital Institutes, were founded in 1926 and today consist of two entities, Instituto Regina Elena (IRE) and Instituto San Gallicano (ISG), located in Rome. The institutes achieve excellence in the prevention, diagnosis and treatment of tumors through research in the epidemiological, etiological, transformation and neoplastic progression, and experimental therapies. Some diagnostic and therapeutic services such as Nuclear Medicine, PET and Radiotherapy are among the most modern and cutting edge in the European healthcare system.

Please reload

  • Grey Facebook Icon
  • Grey LinkedIn Icon
  • Grey Twitter Icon

CONTACT US

Are you looking to participate in clinical trials?

Take our self-assessment test to find potentially suitable studies.

For other inquiries, please visit our contact page.